» Articles » PMID: 33140889

Network Pharmacology and Molecular Docking Analyses on Lianhua Qingwen Capsule Indicate Akt1 is a Potential Target to Treat and Prevent COVID-19

Overview
Journal Cell Prolif
Date 2020 Nov 3
PMID 33140889
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Coronavirus disease 2019 (COVID-19) is rapidly spreading worldwide. Lianhua Qingwen capsule (LQC) has shown therapeutic effects in patients with COVID-19. This study is aimed to discover its molecular mechanism and provide potential drug targets.

Materials And Methods: An LQC target and COVID-19-related gene set was established using the Traditional Chinese Medicine Systems Pharmacology database and seven disease-gene databases. Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis and protein-protein interaction (PPI) network were performed to discover the potential mechanism. Molecular docking was performed to visualize the patterns of interactions between the effective molecule and targeted protein.

Results: A gene set of 65 genes was generated. We then constructed a compound-target network that contained 234 nodes of active compounds and 916 edges of compound-target pairs. The GO and KEGG indicated that LQC can act by regulating immune response, apoptosis and virus infection. PPI network and subnetworks identified nine hub genes. The molecular docking was conducted on the most significant gene Akt1, which is involved in lung injury, lung fibrogenesis and virus infection. Six active compounds of LQC can enter the active pocket of Akt1, namely beta-carotene, kaempferol, luteolin, naringenin, quercetin and wogonin, thereby exerting potential therapeutic effects in COVID-19.

Conclusions: The network pharmacological strategy integrates molecular docking to unravel the molecular mechanism of LQC. Akt1 is a promising drug target to reduce tissue damage and help eliminate virus infection.

Citing Articles

Integrated computational analysis of molecular mechanisms underlying perfluorooctane sulfonic acid induced thyroid toxicity.

Li H, Yu B, Yuan Y, Chen N, Guo H, Zhang H Sci Rep. 2025; 15(1):7920.

PMID: 40050647 PMC: 11885520. DOI: 10.1038/s41598-025-92678-2.


The Multi-Target Action Mechanism for the Anti-Periodontitis Effect of Based on Bioinformatics Analysis and In Vitro Verification.

Li N, Wang B, Yang M, Feng M, Xu X, Xian C Nutrients. 2025; 17(4).

PMID: 40004956 PMC: 11858088. DOI: 10.3390/nu17040627.


Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis.

Byregowda B, Baby K, Maity S, Nayak U, S G, Fayaz S F1000Res. 2025; 13:216.

PMID: 39931327 PMC: 11809647. DOI: 10.12688/f1000research.142513.1.


Reveal the potent antidepressant effects of Zhi-Zi-Hou-Pu Decoction based on integrated network pharmacology and DDI analysis by deep learning.

Zhang Z, Li X, Huang Z, Pan Z, Li L, Wang Y Heliyon. 2024; 10(22):e38726.

PMID: 39641032 PMC: 11617927. DOI: 10.1016/j.heliyon.2024.e38726.


Anti-anemic potential of L. in iron-deficient rat model; network pharmacology profiling.

Javed S, Shahzadi Z, Yousaf Z, Anjum I, Aftab A, Hanif S Food Sci Nutr. 2024; 12(10):7331-7346.

PMID: 39479620 PMC: 11521654. DOI: 10.1002/fsn3.4314.


References
1.
Wang Y, Bryant S, Cheng T, Wang J, Gindulyte A, Shoemaker B . PubChem BioAssay: 2017 update. Nucleic Acids Res. 2016; 45(D1):D955-D963. PMC: 5210581. DOI: 10.1093/nar/gkw1118. View

2.
Pinero J, Bravo A, Queralt-Rosinach N, Gutierrez-Sacristan A, Deu-Pons J, Centeno E . DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2016; 45(D1):D833-D839. PMC: 5210640. DOI: 10.1093/nar/gkw943. View

3.
Lee C, Chen R, Liu J, Yeh W, Chang J, Liu P . Altered p38 mitogen-activated protein kinase expression in different leukocytes with increment of immunosuppressive mediators in patients with severe acute respiratory syndrome. J Immunol. 2004; 172(12):7841-7. DOI: 10.4049/jimmunol.172.12.7841. View

4.
Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y . SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020; 13(1):120. PMC: 7471641. DOI: 10.1186/s13045-020-00954-7. View

5.
Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View